🎁 Final Month Special: 15% OFF + Free Shipping on Most Items! Don't Miss Out - Shop Now! ✨

Shopping Cart

Sub Total: $0.00
Total: $0.00
Checkout

Search Products

Adenosine Injection 6mg/2ml Vial for Intravenous (IV) Use Image 1
View Media Gallery
Adenosine Injection 6mg/2ml Vial for Intravenous (IV) Use Image 2
View Media Gallery
Adenosine Injection 6mg/2ml Vial for Intravenous (IV) Use Nav Image 1
Adenosine Injection 6mg/2ml Vial for Intravenous (IV) Use Nav Image 2

Adenosine Injection 6mg/2ml Vial for Intravenous (IV) Use

$82.99 $97.00


Tags:

Adenosine Cardiac Healthcare Hospital Injection IV mcenter Pharma Supraventricular Tachycardia WolffParkinsonWhite


Categories:

Pharmaceutical
Estimated Delivery:
0 people are viewing this right now
Guaranteed Safe Checkout
Trust
Trust
  • Description

Adenosine Injection 6mg/2ml Vial

Adenosine Injection is a pharmaceutical product used primarily for the treatment of paroxysmal supraventricular tachycardia, a condition characterized by rapid heartbeats. This injection is administered intravenously and is intended for hospital use only, ensuring that cardiorespiratory resuscitation equipment is available for immediate use. Adenosine works by slowing down the electrical impulses that control heart rhythm, allowing the heart to return to its normal rhythm.

Key Features
  • Active Ingredient Adenosine
  • Concentration 6mg/2ml
  • Administration Rapid Intravenous Bolus
  • Use Hospital Use Only
Application or Use Case

Primarily used for the rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts such as Wolff-Parkinson-White syndrome.

Typical User/Industry Profile

Healthcare professionals in hospital settings, particularly those specializing in cardiology and emergency medicine.

About the Brand

Adenocor, manufactured by Sanofi, is a trusted name in the pharmaceutical industry, known for its innovative solutions in cardiac care. Sanofi's commitment to quality and efficacy makes it a leader in the field of cardiovascular treatments.